7.
Florian R, Kraft F, Leitao E, Kaya S, Klebe S, Magnin E
. Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3. Nat Commun. 2019; 10(1):4919.
PMC: 6820781.
DOI: 10.1038/s41467-019-12763-9.
View
8.
Pan S, Li X, Li L, Lin H, Wang D, Zhang X
. Comprehensive genetic, clinical and electrophysiological studies of familial cortical myoclonic tremor with epilepsy 1 highlight the role of gene configurations. Seizure. 2021; 87:69-74.
DOI: 10.1016/j.seizure.2021.02.026.
View
9.
Depienne C, van den Maagdenberg A, Kuhnel T, Ishiura H, Corbett M, Tsuji S
. Insights into familial adult myoclonus epilepsy pathogenesis: How the same repeat expansion in six unrelated genes may lead to cortical excitability. Epilepsia. 2023; 64 Suppl 1:S31-S38.
DOI: 10.1111/epi.17504.
View
10.
Lagorio I, Zara F, Striano S, Striano P
. Familial adult myoclonic epilepsy: A new expansion repeats disorder. Seizure. 2019; 67:73-77.
DOI: 10.1016/j.seizure.2019.03.009.
View
11.
Dubbioso R, Suppa A, Tijssen M, Ikeda A
. Familial adult myoclonus epilepsy: Neurophysiological investigations. Epilepsia. 2023; 64 Suppl 1:S39-S46.
DOI: 10.1111/epi.17553.
View
12.
Franceschetti S, Visani E, Panzica F, Coppola A, Striano P, Canafoglia L
. Cortico-muscular coherence and brain networks in familial adult myoclonic epilepsy and progressive myoclonic epilepsy. Clin Neurophysiol. 2023; 151:74-82.
DOI: 10.1016/j.clinph.2023.04.009.
View
13.
van Rootselaar A, Cocozza S, Aronica E, Striano P
. Familial adult myoclonus epilepsy: Neuroimaging and neuropathological findings. Epilepsia. 2023; 64 Suppl 1:S47-S51.
DOI: 10.1111/epi.17628.
View
14.
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L
. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37. Brain. 2018; 141(7):1981-1997.
DOI: 10.1093/brain/awy137.
View
15.
Coppola A, Dubbioso R, Cuccurullo C, Licchetta L, Carreno M, Hirsch E
. Current treatment options for familial adult myoclonus epilepsy. Epilepsia. 2023; 64 Suppl 1:S58-S63.
DOI: 10.1111/epi.17590.
View
16.
Mahadevan R, Viswanathan N, Shanmugam G, Sankaralingam S, Essaki B, Chelladurai R
. Autosomal dominant cortical tremor, myoclonus, and epilepsy (ADCME) in a unique south Indian community. Epilepsia. 2016; 57(3):e56-9.
DOI: 10.1111/epi.13303.
View
17.
Mir A, Alghamdi A, AlOtaibi W, Samreen D, Alotaibi M, Albaradie R
. A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus. Epileptic Disord. 2022; 24(4):633-646.
DOI: 10.1684/epd.2022.1439.
View
18.
Oi K, Neshige S, Hitomi T, Kobayashi K, Tojima M, Matsuhashi M
. Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex. Clin Neurophysiol. 2019; 130(10):1804-1812.
DOI: 10.1016/j.clinph.2019.07.006.
View
19.
Menon R, Baheti N, Cherian A, Iyer R
. Oxcarbazepine induced worsening of seizures in Jeavons syndrome: lessons learnt from an interesting presentation. Neurol India. 2011; 59(1):70-2.
DOI: 10.4103/0028-3886.76867.
View
20.
Striano P, Coppola A, Madia F, Pezzella M, Ciampa C, Zara F
. Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. Epilepsia. 2007; 48(10):1995-8.
DOI: 10.1111/j.1528-1167.2007.01198.x.
View
21.
Wurster C, Ludolph A
. Antisense oligonucleotides in neurological disorders. Ther Adv Neurol Disord. 2018; 11:1756286418776932.
PMC: 5971383.
DOI: 10.1177/1756286418776932.
View